New User? Sign Up Free
SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.
Ludwig H. Lin, MD, and Michael G.S. Shashaty, MD, MS, discuss acute kidney injury (AKI) biomarkers and whether they are ready for clinical use. Current research, key takeaway points, the history of AKI biomarkers, and challenges to adoption are reviewed.
Dr. Shashaty is an assistant professor of medicine at the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, USA.
*If you are unable to play the podcast please click here to download the file.